Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1944 2
1945 3
1946 10
1947 7
1948 6
1949 5
1950 5
1951 4
1952 3
1953 8
1954 9
1955 10
1956 5
1957 8
1958 10
1959 4
1960 4
1961 5
1962 3
1963 2
1964 9
1965 12
1966 9
1967 13
1968 15
1969 11
1970 13
1971 13
1972 7
1973 23
1974 17
1975 14
1976 32
1977 25
1978 23
1979 24
1980 23
1981 30
1982 23
1983 20
1984 28
1985 35
1986 35
1987 43
1988 35
1989 47
1990 48
1991 48
1992 34
1993 44
1994 34
1995 33
1996 26
1997 38
1998 31
1999 34
2000 30
2001 29
2002 29
2003 35
2004 31
2005 30
2006 30
2007 35
2008 32
2009 24
2010 24
2011 31
2012 34
2013 36
2014 23
2015 36
2016 39
2017 37
2018 47
2019 35
2020 49
2021 38
2022 41
2023 39
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,809 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Yurgelun MB, et al. Among authors: mayer rj. J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135145 Free PMC article.
Reply.
Fox JC, Lahham S, Maldonado G, Klaus S, Aish B, Sylwanowicz LV, Yanuck J, Wilson SP, Shieh M, Anderson CL, English C, Mayer R, Mohan UR. Fox JC, et al. Among authors: mayer r. J Ultrasound Med. 2018 Jun;37(6):1576. doi: 10.1002/jum.14441. Epub 2017 Oct 9. J Ultrasound Med. 2018. PMID: 28990214 No abstract available.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C. Venook AP, et al. Among authors: mayer rj. JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105. JAMA. 2017. PMID: 28632865 Free PMC article. Clinical Trial.
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).
Lenz HJ, Ou FS, Venook AP, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Bertagnolli MM, Blanke CD, Zemla T, Qu X, Wirapati P, Tejpar S, Innocenti F, Kabbarah O. Lenz HJ, et al. Among authors: mayer rj. J Clin Oncol. 2019 Aug 1;37(22):1876-1885. doi: 10.1200/JCO.18.02258. Epub 2019 May 1. J Clin Oncol. 2019. PMID: 31042420 Free PMC article. Clinical Trial.
Computer Games in Education.
Mayer RE. Mayer RE. Annu Rev Psychol. 2019 Jan 4;70:531-549. doi: 10.1146/annurev-psych-010418-102744. Epub 2018 Sep 19. Annu Rev Psychol. 2019. PMID: 30231003 Review.
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA. Van Blarigan EL, et al. Among authors: mayer rj. JAMA Oncol. 2018 Jun 1;4(6):783-790. doi: 10.1001/jamaoncol.2018.0126. JAMA Oncol. 2018. PMID: 29710284 Free PMC article. Clinical Trial.
1,809 results